Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Farmers Insurance
Mallinckrodt
Healthtrust
Dow
Citi
US Department of Justice
Fish and Richardson
Boehringer Ingelheim

Generated: July 15, 2018

DrugPatentWatch Database Preview

Indium in-111 oxyquinoline - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for indium in-111 oxyquinoline and what is the scope of indium in-111 oxyquinoline freedom to operate?

Indium in-111 oxyquinoline
is the generic ingredient in one branded drug marketed by Ge Healthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for indium in-111 oxyquinoline. One supplier is listed for this compound.
Summary for indium in-111 oxyquinoline
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 23
Suppliers / Packagers: 1
DailyMed Link:indium in-111 oxyquinoline at DailyMed

US Patents and Regulatory Information for indium in-111 oxyquinoline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare INDIUM IN 111 OXYQUINOLINE indium in-111 oxyquinoline INJECTABLE;INJECTION 019044-001 Dec 24, 1985 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Merck
US Army
Cantor Fitzgerald
Daiichi Sankyo
Medtronic
Express Scripts
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.